Differences in drug treatment of chronic heart failure between European countries
Authors:
- A. CharlesworthACA. Charlesworth
- H.J.G.M. CrijnsHCH.J.G.M. Crijns
- K.I. LieKLK.I. Lie
- J.R. HamptonJHJ.R. Hampton
Open Access
- 1 May 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 20 (9) , 666-672
Abstract
AimsA large number of drugs are currently used for the treatment of chronic heart failure. Treatment for other cardiovascular disorders has been showKeywords
This publication has 8 references indexed in Scilit:
- Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryEuropean Heart Journal, 1999
- Recent National Patterns of Warfarin Use in Atrial FibrillationCirculation, 1998
- Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines 11This work was supported in part by unrestricted grants from Bristol-Myers Squibb Co., Princeton, New Jersey; Burroughs Wellcome Co., Research Triangle Park, North Carolina; Merck & Co., West Point, Pennsylvania; and the Department of Veterans Affairs Research Service.22All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California in San Francisco.JACC, 1997
- Treatment of Patients Admitted to the Hospital With Congestive Heart Failure: Specialty-Related Disparities in Practice Patterns and OutcomesJACC, 1997
- Anticoagulant and antiplatelet therapy in heart failureCurrent Opinion in Cardiology, 1997
- Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialThe Lancet, 1997
- Improving survival for patients with advanced heart failure: A study of 737 consecutive patientsJACC, 1995
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975